142 related articles for article (PubMed ID: 7801735)
1. Follow-up study of MS patients treated with high-dose intravenous methylprednisolone.
Frequin ST; Lamers KJ; Barkhof F; Borm GF; Hommes OR
Acta Neurol Scand; 1994 Aug; 90(2):105-10. PubMed ID: 7801735
[TBL] [Abstract][Full Text] [Related]
2. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
3. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.
Zivadinov R; Rudick RA; De Masi R; Nasuelli D; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
Neurology; 2001 Oct; 57(7):1239-47. PubMed ID: 11591843
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination with i.v. methylprednisolone in the treatment of relapses in patients with MS.
Visser LH; Beekman R; Tijssen CC; Uitdehaag BM; Lee ML; Movig KL; Lenderink AW
Mult Scler; 2004 Feb; 10(1):89-91. PubMed ID: 14760960
[TBL] [Abstract][Full Text] [Related]
5. Re-examining the effects of high-dose intravenous methylprednisolone for secondary progressive multiple sclerosis.
Jalipa FGU; Espiritu AI; Pasco PMD
Neurodegener Dis Manag; 2021 Apr; 11(2):177-185. PubMed ID: 33703936
[TBL] [Abstract][Full Text] [Related]
6. CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone.
Frequin ST; Barkhof F; Lamers KJ; Hommes OR; Borm GF
Acta Neurol Scand; 1992 Sep; 86(3):291-7. PubMed ID: 1384263
[TBL] [Abstract][Full Text] [Related]
7. A transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis.
Fierro B; Salemi G; Brighina F; Buffa D; Conte S; La Bua V; Piazza A; Savettieri G
Acta Neurol Scand; 2002 Mar; 105(3):152-7. PubMed ID: 11886356
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica.
Yamasaki R; Matsushita T; Fukazawa T; Yokoyama K; Fujihara K; Ogino M; Yokota T; Miyamoto K; Niino M; Nomura K; Tomioka R; Tanaka M; Kawachi I; Ohashi T; Kaida K; Matsui M; Nakatsuji Y; Ochi H; Fukaura H; Kanda T; Nagaishi A; Togo K; Mizusawa H; Murai H; Kira J
Mult Scler; 2016 Sep; 22(10):1337-48. PubMed ID: 26564994
[TBL] [Abstract][Full Text] [Related]
9. Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis.
Zivadinov R; Zorzon M; De Masi R; Nasuelli D; Cazzato G
J Neurol Sci; 2008 Apr; 267(1-2):28-35. PubMed ID: 17945260
[TBL] [Abstract][Full Text] [Related]
10. Oral prednisone taper following intravenous steroids fails to improve disability or recovery from relapses in multiple sclerosis.
Perumal JS; Caon C; Hreha S; Zabad R; Tselis A; Lisak R; Khan O
Eur J Neurol; 2008 Jul; 15(7):677-80. PubMed ID: 18459972
[TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
Ramo-Tello C; Grau-López L; Tintoré M; Rovira A; Ramió i Torrenta L; Brieva L; Cano A; Carmona O; Saiz A; Torres F; Giner P; Nos C; Massuet A; Montalbán X; Martínez-Cáceres E; Costa J
Mult Scler; 2014 May; 20(6):717-25. PubMed ID: 24144876
[TBL] [Abstract][Full Text] [Related]
12. T-cell subsets in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients treated with high-dose intravenous methylprednisolone.
Frequin ST; Lamers KJ; Borm GF; Barkhof F; Jongen PJ; Hommes OR
Acta Neurol Scand; 1993 Aug; 88(2):80-6. PubMed ID: 8213063
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis.
Nos C; Sastre-Garriga J; Borràs C; Río J; Tintoré M; Montalban X
Mult Scler; 2004 Aug; 10(4):413-6. PubMed ID: 15327039
[TBL] [Abstract][Full Text] [Related]
14. High-dose methylprednisolone infusions in relapsing and in chronic progressive multiple sclerosis patients. One year follow-up.
Bergamaschi R; Versino M; Raiola E; Citterio A; Cosi V
Acta Neurol (Napoli); 1993 Feb; 15(1):33-43. PubMed ID: 8456594
[TBL] [Abstract][Full Text] [Related]
15. Prevention of rebound effect after natalizumab withdrawal in multiple sclerosis. Study of two high-dose methylprednisolone schedules.
Fuentes-Rumí L; Hernández-Clares R; Carreón-Guarnizo E; Valero-López G; Iniesta-Martinez F; Cabrera-Maqueda JM; León-Hernández A; Zamarro-Parra J; Morales-Ortiz A; Meca-Lallana JE
Mult Scler Relat Disord; 2020 Sep; 44():102311. PubMed ID: 32593958
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the long term effect of mitoxantrone on neurological disability in patients with active multiple sclerosis].
Mesaros S; Stojsavljević N; Dujmović I; Mandić E; Drulović J
Srp Arh Celok Lek; 2004; 132(7-8):209-13. PubMed ID: 15615176
[TBL] [Abstract][Full Text] [Related]
17. Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications.
Fox RJ; Fisher E; Tkach J; Lee JC; Cohen JA; Rudick RA
Mult Scler; 2005 Apr; 11(2):140-5. PubMed ID: 15794385
[TBL] [Abstract][Full Text] [Related]
18. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
[TBL] [Abstract][Full Text] [Related]
19. Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis.
Patzold T; Schwengelbeck M; Ossege LM; Malin JP; Sindern E
Acta Neurol Scand; 2002 Mar; 105(3):164-8. PubMed ID: 11886358
[TBL] [Abstract][Full Text] [Related]
20. Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange.
Abboud H; Petrak A; Mealy M; Sasidharan S; Siddique L; Levy M
Mult Scler; 2016 Feb; 22(2):185-92. PubMed ID: 25921047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
